Syncona Limited NPV (SYNC) RNS Announcements

Add to Alert list
Date Time Source Announcement
11 Nov 2021 07:00 AM
RNS
Half-year Report
10 Nov 2021 07:00 AM
RNS
Freeline reports new data and 3rd Quarter Results
09 Nov 2021 01:31 PM
RNS
Achilles reports Third Quarter Financial Results
08 Nov 2021 01:05 PM
RNS
Gyroscope Announces Sanofi Equity Investment
08 Nov 2021 07:00 AM
RNS
Blackstone Life Science to invest $250m in Autolus
03 Nov 2021 11:07 AM
RNS
Syncona leads $87 million financing of Clade
03 Nov 2021 11:05 AM
RNS
Autolus reports Q3 2021 Financial Results
26 Oct 2021 07:00 AM
RNS
Notice of Results
30 Sep 2021 03:59 PM
RNS
Gyroscope announces additional positive data
17 Aug 2021 07:00 AM
RNS
First Quarter Update
16 Aug 2021 12:07 PM
RNS
Freeline Reports Executive Change and Q2 Results
10 Aug 2021 12:05 PM
RNS
Achilles reports Second Quarter 2021 Results
05 Aug 2021 12:05 PM
RNS
Autolus reports Q2 2021 Financial Results
03 Aug 2021 01:16 PM
RNS
Result of AGM - Replacement
03 Aug 2021 12:32 PM
RNS
Result of AGM
30 Jul 2021 12:17 PM
RNS
Total Voting Rights
27 Jul 2021 02:41 PM
RNS
Holding(s) in Company
15 Jul 2021 12:57 PM
RNS
Issue of shares pursuant to incentive scheme
01 Jul 2021 11:54 AM
RNS
Publication of 2021 Annual Report & Notice of AGM
24 Jun 2021 07:00 AM
RNS
Anaveon doses first patient in Phase I/II study
17 Jun 2021 07:00 AM
RNS
Final Results
17 Jun 2021 07:00 AM
RNS
Syncona announces expansion of leadership team
11 Jun 2021 12:05 PM
RNS
Autolus to present additional data in AUTO1
18 May 2021 07:00 AM
RNS
Notice of Results
18 May 2021 07:00 AM
RNS
Freeline reports Q1 results
12 May 2021 03:05 PM
RNS
Autolus to present additional data in AUTO1
12 May 2021 01:18 PM
RNS
Director/PDMR Shareholding
11 May 2021 12:05 PM
RNS
Achilles reports Q1 financial results
07 May 2021 07:00 AM
RNS
Gyroscope Therapeutics update on proposed IPO
06 May 2021 12:05 PM
RNS
Autolus reports Q1 2021 Financial Results
04 May 2021 07:00 AM
RNS
Update on Gyroscope proposed IPO in the US
19 Apr 2021 12:05 PM
RNS
Autolus appoints non-executive Chair
19 Apr 2021 07:00 AM
RNS
Gyroscope files registration statement
06 Apr 2021 04:00 PM
RNS
Director/PDMR Shareholding
01 Apr 2021 07:00 AM
RNS
Freeline Reports Financial Results
31 Mar 2021 07:00 AM
RNS
Achilles update on IPO
30 Mar 2021 12:04 PM
RNS
Director/PDMR Shareholding
26 Mar 2021 07:06 AM
RNS
Gyroscope announces additional financing plans
26 Mar 2021 07:00 AM
RNS
Syncona cornerstones $148m Series C in Gyroscope
25 Mar 2021 11:13 AM
RNS
Update on Achilles' proposed IPO
04 Mar 2021 12:10 PM
RNS
Autolus Reports Full Year 2020 Financial Results
02 Mar 2021 07:00 AM
RNS
Achilles files registration statement
12 Feb 2021 03:49 PM
RNS
Gyroscope Announces Positive Interim Data
11 Feb 2021 07:00 AM
RNS
New commitment to Quell in largest ever Series A
11 Feb 2021 07:00 AM
RNS
Quarterly and Business Update
10 Feb 2021 07:00 AM
RNS
Autolus announces pricing of public offering
08 Feb 2021 12:09 PM
RNS
Freeline Updates Clinical Development Plan
05 Feb 2021 07:00 AM
RNS
Achilles announces additional financing plans
05 Feb 2021 07:00 AM
RNS
Achilles data and safety committee review
06 Jan 2021 07:00 AM
RNS
Autolus Business Outlook

Syncona Limited is a Guernsey-based investment company focusing on long-term capital appreciation through investments in life science businesses and single or multi-asset projects. The company aims to build a diversified portfolio of global healthcare companies, with a focus on developing treatments for patients by partnering with academic founders and management teams. Syncona's investment objective is to achieve superior long-term capital appreciation.

Syncona share price launched at 104p in 2012.

UK 100

Latest directors dealings